首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Absence of Association between Polymorphisms in the RING E3 Ubiquitin Protein Ligase Gene and Ex Vivo Susceptibility to Conventional Antimalarial Drugs in Plasmodium falciparum Isolates from Dakar Senegal
【2h】

Absence of Association between Polymorphisms in the RING E3 Ubiquitin Protein Ligase Gene and Ex Vivo Susceptibility to Conventional Antimalarial Drugs in Plasmodium falciparum Isolates from Dakar Senegal

机译:塞内加尔达喀尔的恶性疟原虫中RING E3泛素蛋白连接酶基因多态性与常规抗疟药易感性之间没有关联

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The RING E3 ubiquitin protein ligase is crucial for facilitating the transfer of ubiquitin. The only polymorphism identified in the E3 ubiquitin protein ligase gene was the D113N mutation (62.5%) but was not significantly associated with the 50% inhibitory concentration (IC50) of conventional antimalarial drugs. However, some mutated isolates (D113N) present a trend of reduced susceptibility to piperaquine (P = 0.0938). To evaluate the association of D113N polymorphism with susceptibility to antimalarials, more isolates are necessary.
机译:RING E3泛素蛋白连接酶对于促进泛素的转移至关重要。在E3泛素蛋白连接酶基因中鉴定出的唯一多态性是D113N突变(62.5%),但与常规抗疟药的50%抑制浓度(IC50)并不显着相关。但是,某些突变菌株(D113N)呈现出对哌喹敏感性降低的趋势(P = 0.0938)。为了评估D113N多态性与抗疟药药敏感性的关系,需要更多的分离株。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号